InVivoSIM anti-human PD-1 (Nivolumab Biosimilar)
SIM0003
ApplicationsFunctional Assay, Flow Cytometry, Western Blot, ImmunoHistoChemistry, Neutralisation/Blocking
Product group Antibodies
Overview
- SupplierBio X Cell
- Product NameInVivoSIM anti-human PD-1 (Nivolumab Biosimilar)
- Delivery Days Customer7
- ApplicationsFunctional Assay, Flow Cytometry, Western Blot, ImmunoHistoChemistry, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDNivolumab
- Concentration4-11 mg/ml
- Estimated Purity>95%
- HostHuman
- IsotypeIgG4
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Anti-PD-1 therapy triggers Tfh cell-dependent IL-4 release to boost CD8 T cell responses in tumor-draining lymph nodes.Read more
- Stromal depletion by TALEN-edited universal hypoimmunogenic FAP-CAR T cells enables infiltration and anti-tumor cytotoxicity of tumor antigen-targeted CAR-T immunotherapy.Read more
- YIV-906 enhances nuclear factor of activated T-cells (NFAT) activity of T cells and promotes immune checkpoint blockade antibody action and CAR T-cell activity.Read more
Related products
Product group Antibodies
References
ApplicationsFlow Cytometry, Western Blot
- SizePrice
Product group Antibodies
- SizePrice
Product group Antibodies
References
ApplicationsFunctional Assay, Neutralisation/Blocking
- SizePrice
Product group Antibodies
ApplicationsFunctional Assay, ELISA, Neutralisation/Blocking
- SizePrice
Product group Antibodies
ApplicationsFunctional Assay, ELISA, Neutralisation/Blocking
- SizePrice